Altman Peter 4

What Happened

Peter Altman, President, CEO and a director of BioCardia, Inc. (BCDA), acquired 5,000 shares on 2026-04-29 at $1.11 per share, for a total reported cost of $5,550. The Form 4 lists the transaction as a purchase (code P), described as an open market or private purchase. As a buy, this is a direct insider purchase rather than a sale.

Key Details

• Transaction date: 2026-04-29
• Price per share: $1.11; total value: $5,550
• Transaction type/code: Purchase (P) — open market or private purchase per filing
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing date / Period of Report: 2026-04-29 (filing appears timely; no late filing indicated)
• Footnotes/notable disclosures: None reported in the provided excerpt

Context

Insider purchases can be viewed by investors as a positive signal, though the economic size here is small ($5.6k), so it should be weighed accordingly with other information about the company and its financials. This was a straightforward equity purchase—not an option exercise, gift, or tax withholding event.